PCN4: Economic Consequences of Differneces in the Adverse-Events (AE) Profile of Capecitabine vs. Mayo Clinic (M) -Regimen in Previously Untreated Advanced/Metastatic Colorectal Cancer : International Society for Pharmacoeconomics and Outcomes Research
In: VALUE IN HEALTH 3(NO 5):351-351; Jg. 3 (2000) NO 5, S. 351-351
Online
Konferenz
Zugriff:
Titel: |
PCN4: Economic Consequences of Differneces in the Adverse-Events (AE) Profile of Capecitabine vs. Mayo Clinic (M) -Regimen in Previously Untreated Advanced/Metastatic Colorectal Cancer : International Society for Pharmacoeconomics and Outcomes Research
|
---|---|
Autor/in / Beteiligte Person: | Hieke, K. ; Twelves, C. ; Boyer, M. ; Findlay, M. ; Weitzel, C. ; Barker, C. ; Osterwalder, B. ; Jamieson, C. |
Link: | |
Quelle: | VALUE IN HEALTH 3(NO 5):351-351; Jg. 3 (2000) NO 5, S. 351-351 |
Veröffentlichung: | 2000 |
Medientyp: | Konferenz |
ISSN: | 1098-3015 (print) |
Sonstiges: |
|